February 15, 2023

Cause for Optimism
Interview by T.C. Lowrie | Business Partners, Jan-Feb, 2023

Health MattersBy admin February 15, 2023

Dr. Leonidas Platanias is a world-renowned oncologist, whose work in molecular biology and biochemistry, particularly his research on interferons and cytokines, has been an invaluable contribution to immunotherapy and the fight against cancer. On the occasion of his participation in HealthWorld 2022, Business Partners reached out to him to talk about his work in cancer…

United, We Make Disease a Thing of the Past
By Business Partners | Jan-Feb, 2023

The InterviewBy admin February 15, 2023

Christian Rodseth, Managing Director of Janssen Greece, Poland and Romania, has 20 years of experience in the pharmaceutical industry and has been a member of the Janssen family, Pharmaceutical Companies of Johnson & Johnson, since 2006. Committed to serving company’s mission to the humanity, he has taken on key leadership roles, including as Global Commercial…

Director’s Desk
By Elias Spirtounias, Executive Director | Business Partners Jan-Feb, 2023

First PersonBy admin February 15, 2023

As I sat down to write the first editorial for 2023, I began reflecting on the important issues and developments, at a national and global level, that will determine how this year unfolds: the war in Ukraine, the outcome of which will decide geopolitical balances and their implications not only in Europe but around the…

Cause for OptimismInterview by T.C. Lowrie | Business Partners, Jan-Feb, 2023

United, We Make Disease a Thing of the PastBy Business Partners | Jan-Feb, 2023

Director’s DeskBy Elias Spirtounias, Executive Director | Business Partners Jan-Feb, 2023

Cause for Optimism
Interview by T.C. Lowrie | Business Partners, Jan-Feb, 2023

United, We Make Disease a Thing of the Past
By Business Partners | Jan-Feb, 2023

Director’s Desk
By Elias Spirtounias, Executive Director | Business Partners Jan-Feb, 2023